Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda, not surprisingly, is rather modest. We plan to tackle sundry chores, catch up on some reading and promenade with the official mascot. And what about you? This is a lovely time of year to enjoy the great outdoors. You could reach out to someone who is feeling isolated these days. You could also plan ahead to make sure you are registered to vote, however you may cast your ballot. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …

Elizabeth Nabel, president of Brigham and Women’s Hospital, is resigning from the Moderna (MRNA) board in response to questions about whether her role at the biotech is a conflict of interest since her hospital is participating in a large study of Moderna’s experimental Covid-19 vaccine that just began, The Boston Globe reports. The study is being led partly by a Brigham infectious diseases specialist, who also is helping to run the nationwide testing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.